| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/PLAC.2002.0930 |
| P698 | PubMed publication ID | 12842410 |
| P2093 | author name string | Redman CW | |
| Sargent IL | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | S21-7 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Placenta | Q7200288 |
| P1476 | title | Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review | |
| P478 | volume | 24 Suppl A |
| Q64261280 | A Comparative Study of Fractionated Versus Single Dose Injection for Spinal Anesthesia During Cesarean Section in Patients with Pregnancy-Induced Hypertension |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q37160772 | A Novel ERAP2 Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk. |
| Q27007734 | A clear and present danger: inflammasomes DAMPing down disorders of pregnancy |
| Q34267851 | A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder |
| Q90114753 | A maternal GOT1 novel variant associated with early-onset severe preeclampsia identified by whole-exome sequencing |
| Q55251086 | A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women. |
| Q82661036 | Abnormal levels of antioxidant defenses in a large sample of patients with hypertensive disorders of pregnancy |
| Q54638541 | Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. |
| Q38092844 | Adenosine deaminase activity in normal pregnancy and pregnancy associated disorders |
| Q42221088 | Altered autophagy induction by sera from pregnant women with pre-eclampsia: a case-control study |
| Q37899204 | Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis |
| Q33348850 | Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia |
| Q33329370 | Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry |
| Q37353499 | Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension |
| Q80969679 | Animal models of preeclampsia |
| Q48133399 | Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks. |
| Q37989302 | Antioxidant therapies: a potential role in perinatal medicine. |
| Q34618522 | Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study |
| Q37162344 | Association of Maternal Antiangiogenic Profile at Birth With Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies |
| Q37348150 | Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia |
| Q37709091 | Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women |
| Q35535932 | Bioinformatic approach to the genetics of preeclampsia |
| Q35139213 | Biological functions of thyroid hormone in placenta |
| Q29041978 | Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies |
| Q43506535 | Blood pressure rises more in pre-eclampsia than normal pregnancy when acral skin is locally cooled |
| Q46340423 | Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes |
| Q39775299 | Cell migration in BeWo cells and the role of epithelial sodium channels |
| Q52981622 | Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. |
| Q40041343 | Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women |
| Q39674071 | Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia. |
| Q47831280 | Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. |
| Q51936747 | Clinical correlation between adenosine deaminase activity and pre-eclampsia severity. |
| Q64905439 | Combination of Genetic Markers and Age Effectively Facilitates the Identification of People with High Risk of Preeclampsia in the Han Chinese Population. |
| Q57671343 | Complement Factor H Variant Y402H is Not a Risk Factor for Preeclampsia in the Finnish Population |
| Q51464431 | Complement component C1q as potential diagnostic but not predictive marker of preeclampsia. |
| Q36979292 | Correlation between First and Second Trimester Uterine Artery Doppler Velocimetry and Placental Bed Histopathology |
| Q36325124 | Could antioxidant supplementation prevent pre-eclampsia? |
| Q37358198 | Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia |
| Q35107075 | Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments |
| Q46585274 | Detection and identification of novel metabolomic biomarkers in preeclampsia |
| Q38810728 | Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas |
| Q34777981 | Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia |
| Q46725519 | Dimethyl acetals, an indirect marker of the endogenous antioxidant plasmalogen level, are reduced in blood lipids of Sudanese pre-eclamptic subjects whose background diet is high in carbohydrate |
| Q58434441 | Do preeclampsia symptoms resolve after intrauterine death of a fetus? |
| Q36102168 | Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study |
| Q46306925 | Dynamics of Base Excision Repair at the Maternal-Fetal Interface in Pregnancies Complicated by Preeclampsia |
| Q37607702 | Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes |
| Q64097604 | Early pregnancy exposure to endocrine disrupting chemical mixtures are associated with inflammatory changes in maternal and neonatal circulation |
| Q35605794 | Effect of indoor air pollution from biomass and solid fuel combustion on symptoms of preeclampsia/eclampsia in Indian women |
| Q33779180 | Effect of lipoxin A₄ on IL-1β production of monocytes and its possible mechanism in severe preeclampsia |
| Q53594607 | Effects of serum from patients with early-onset pre-eclampsia, HELLP syndrome, and antiphospholipid syndrome on fatty acid oxidation in trophoblast cells. |
| Q37674591 | Embryonic resorption and polycyclic aromatic hydrocarbons: putative immune-mediated mechanisms |
| Q35547367 | Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes |
| Q35656220 | Endogenous and Uric Acid-Induced Activation of NLRP3 Inflammasome in Pregnant Women with Preeclampsia |
| Q36590924 | Endogenous inhibitors of nitric oxide and preeclampsia: a review |
| Q92214395 | Endometrial lymphocyte concentrations in adverse reproductive outcome populations |
| Q27004643 | Endothelial dysfunction and preeclampsia: role of oxidative stress |
| Q33815618 | Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia |
| Q43167336 | Erythrocyte antioxidant enzymes and plasma antioxidant vitamins in Sudanese women with pre-eclampsia |
| Q43258256 | Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1/Th2 cytokine production from normal placental explants via intracellular calcium. |
| Q92442512 | Expression of Retinoid Acid Receptor-Responsive Genes in Rodent Models of Placental Pathology |
| Q83947428 | Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies |
| Q92287969 | Expression profile of Let-7s in peripheral blood mononuclear cells of normal and severe preeclampsia pregnant women |
| Q38837378 | Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction |
| Q45346988 | Factor V Leiden mutation and pregnancy-related complications |
| Q40402667 | Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. |
| Q98613250 | Family history of chronic illness, preterm gestational age and smoking exposure before pregnancy increases the probability of preeclampsia in Omo district in southern Ethiopia: a case-control study |
| Q21261491 | Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study |
| Q44411319 | Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia |
| Q39112949 | First and second trimester immune biomarkers in preeclamptic and normotensive women. |
| Q35362708 | Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice |
| Q36527066 | Future directions of failed implantation and recurrent miscarriage research |
| Q44692373 | Genome profiles in maternal blood during early onset preeclampsia and towards term |
| Q33794472 | Gestational Diabetes Mellitus Is Associated with Altered Neutrophil Activity |
| Q37280695 | Gestational diabetes and pre-eclampsia: common antecedents? |
| Q36751031 | Gestational diabetes and preeclampsia in association with air pollution at levels below current air quality guidelines |
| Q89624335 | HSPA1L rs1061581 polymorphism is associated with the risk of preeclampsia in Han Chinese women |
| Q35627269 | Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation |
| Q64039787 | Hemophagocytic Lymphohistiocytosis in Pregnancy: A Case Series and Review of the Current Literature |
| Q46340735 | Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia |
| Q40111116 | Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice |
| Q64227446 | Immune imbalance is associated with the development of preeclampsia |
| Q47550799 | Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father |
| Q45089554 | Immunological exposures in Norwegian agriculture and pre-eclampsia |
| Q36684096 | Immunoregulation in normal pregnancy and pre-eclampsia: an overview |
| Q56899058 | Immunoregulatory gene polymorphisms in women with preeclampsia |
| Q38846766 | Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia? |
| Q47259373 | Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice |
| Q43647467 | Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia |
| Q34505704 | In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy |
| Q57671312 | Increased Postnatal Inflammation in Mechanically Ventilated Preterm Infants Born to Mothers with Early-Onset Preeclampsia |
| Q51731766 | Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia. |
| Q37850374 | Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia |
| Q44595585 | Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia |
| Q33658840 | Innate immune system and preeclampsia |
| Q46150307 | Interactions between inflammatory and oxidative stress in preeclampsia |
| Q34183082 | Interleukin-1β-31C/T and -511T/C polymorphisms were associated with preeclampsia in Chinese Han population |
| Q47229638 | Intrauterine inflammation increases materno-fetal transfer of gold nanoparticles in a size-dependent manner in murine pregnancy |
| Q34927088 | Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q26774886 | Late postpartum eclampsia complicated with posterior reversible encephalopathy syndrome: a case report and a literature review |
| Q55554947 | Magnesium Supplementation and Blood Pressure in Pregnancy: A Double-Blind Randomized Multicenter Study. |
| Q92608601 | Maternal Multiple Micronutrient Supplementation Stabilizes Mitochondrial DNA Copy Number in Pregnant Women in Lombok, Indonesia |
| Q38912638 | Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: a longitudinal cohort study |
| Q39395309 | Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. |
| Q34987364 | Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England |
| Q34582266 | Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells |
| Q55004295 | Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. |
| Q37857465 | Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension |
| Q34495512 | Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women |
| Q34877450 | Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003 |
| Q89998766 | Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation |
| Q33686011 | Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. |
| Q33774895 | Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities |
| Q38172587 | MicroRNAs: are they the missing link between hypoxia and pre-eclampsia? |
| Q36672096 | Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls |
| Q35921864 | NK cells and trophoblasts: partners in pregnancy |
| Q46909351 | Neutrophil function during pregnancy: is nitric oxide production correlated with superoxide production? |
| Q33382278 | Non-synonymous sequence variants within the oxygen-dependent degradation domain of the HIF1A gene are not associated with pre-eclampsia in the Finnish population |
| Q28386182 | Novel biomarkers for predicting preeclampsia |
| Q37809490 | Obesity and oxidative stress: a direct link to preeclampsia? |
| Q34518301 | Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series |
| Q91968941 | Optical coherence tomography angiography findings in preeclampsia |
| Q37039719 | Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation. |
| Q60949465 | Oxidative Stress as Cause, Consequence, or Biomarker of Altered Female Reproduction and Development in the Space Environment |
| Q59633631 | Oxidative stress |
| Q36214345 | Oxidative stress and inflammation in retained placenta: a pilot study of protein and gene expression of GPX1 and NFκB |
| Q28082703 | Oxidative stress in obesity: a critical component in human diseases |
| Q34119118 | Oxidative stress-mediated aging during the fetal and perinatal periods. |
| Q36446678 | PPAR Action in Human Placental Development and Pregnancy and Its Complications |
| Q35903893 | Partial correlation network analyses to detect altered gene interactions in human disease: using preeclampsia as a model |
| Q24649934 | Pathophysiology of placentation abnormalities in pregnancy-induced hypertension |
| Q44314054 | Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia |
| Q49887531 | Peripapillary retinal nerve fiber layer thickness in preeclampsia and eclampsia. |
| Q34368884 | Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. |
| Q36903108 | Peroxisome proliferator-activated receptors: new players in the field of reproduction |
| Q34556073 | Persistence of decidual NK cells and KIR genotypes in healthy pregnant and preeclamptic women: a case-control study in the third trimester of gestation |
| Q55036804 | Pilot study of placental tissue collection, processing, and measurement procedures for large scale assessment of placental inflammation. |
| Q45035228 | Placenta-derived exosomes: potential biomarkers of preeclampsia |
| Q36907975 | Placental Vacuolar ATPase Function Is a Key Link between Multiple Causes of Preeclampsia |
| Q36107552 | Placental expression of D6 decoy receptor in preeclampsia |
| Q40520851 | Placental leptin mRNA expression and serum leptin levels in pre-eclampsia associated with HIV infection |
| Q37822751 | Placental microparticles, DNA, and RNA in preeclampsia |
| Q36480074 | Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. |
| Q34908922 | Placentation abnormalities in the pathophysiology of preeclampsia |
| Q92903848 | Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia |
| Q37332205 | Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia |
| Q36682012 | Polymorphisms of the IL27 gene in a Chinese Han population complicated with pre-eclampsia |
| Q90112046 | Postpartum blood pressure trends are impacted by race and BMI |
| Q38584627 | Potential role of folate in pre-eclampsia |
| Q81446389 | Pre-eclampsia |
| Q33796455 | Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles |
| Q41105893 | Predicting preeclampsia from a history of preterm birth |
| Q38252740 | Prediction of preeclampsia-bench to bedside |
| Q36691079 | Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells |
| Q36376515 | Preeclampsia: the death of Goliath |
| Q37512886 | Preeclampsia: the role of angiogenic factors in its pathogenesis |
| Q34221152 | Pregnancy close to the edge: an immunosuppressive infiltrate in the chorionic plate of placentas from uncomplicated egg cell donation |
| Q36965261 | Pregnancy induced haemophagocytic syndrome |
| Q36945231 | Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers |
| Q28395340 | Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stress |
| Q36566903 | Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q34404445 | Recent insights into the pathophysiology of preeclampsia |
| Q38991536 | Relation between Helicobacter pylori infection and severe pre-eclampsia complicated by intrauterine growth restriction in a rural area in Egypt |
| Q46495748 | Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension |
| Q58205340 | Renal Interlobar Vein Impedance Index as a First-Trimester Marker Does Not Predict Hypertensive Disorders of Pregnancy |
| Q28395942 | Renal redox response to normal pregnancy in the rat |
| Q87197320 | Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia |
| Q36875755 | Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia |
| Q35171916 | Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility |
| Q36289734 | Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk |
| Q36281978 | Soluble vascular cell adhesion molecule-1 and magnesium sulfate with nifedipine treatment in Indonesian women with severe pre-eclampsia |
| Q38000338 | Statins and pregnancy: between supposed risks and theoretical benefits. |
| Q37825689 | Stroke during pregnancy and puerperium: clinical perspectives |
| Q61847486 | TYPE 1 DIABETES IN PREGNANCY; INFLUENCES ON MOTHER AND FETUS |
| Q60046051 | The Mitochondrion as Potential Interface in Early-Life Stress Brain Programming |
| Q36176031 | The Pre-Eclampsia Ontology: A Disease Ontology Representing the Domain Knowledge Specific to Pre-Eclampsia |
| Q92068774 | The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review |
| Q35879299 | The biology and diagnostic applications of fetal DNA and RNA in maternal plasma |
| Q36189692 | The effect of healthy pregnant plasma and preeclamptic plasma on the phagocytosis index of neutrophil granulocytes and monocytes of nonpregnant women |
| Q33919724 | The immunomodulatory role of syncytiotrophoblast microvesicles. |
| Q35210096 | The importance of antioxidant micronutrients in pregnancy |
| Q34742376 | The netrin receptor UNC5B promotes angiogenesis in specific vascular beds |
| Q24795491 | The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia |
| Q57787116 | The relationship between inflammatory factor expression and blood pressure and urinary protein in the placenta of gestational hypertension rats |
| Q36019933 | The twin placenta: framework for gross analysis in fetal origins of adult disease initiatives |
| Q39933840 | The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time? |
| Q38316934 | Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis. |
| Q40196259 | Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes |
| Q24323351 | Tissue factor and its natural inhibitor in pre-eclampsia and SGA |
| Q37623527 | Toll-like receptors in pregnancy disorders and placental dysfunction |
| Q58730340 | Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells |
| Q35871466 | Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia |
| Q34481622 | Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women |
| Q44275157 | Umbilical artery serum chitotriosidase concentration in pregnancies complicated by preeclampsia and relationship between chitotriosidase levels and fetal blood flow velocity. |
| Q37430265 | Uterine artery pulsatility index in hypertensive pregnancies: When does the index normalize in the puerperium? |
| Q28070253 | Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia |
| Q50507287 | [Pathoanatomical and clinical aspects of the placenta in preterm birth]. |
Search more.